JP2018510131A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510131A5 JP2018510131A5 JP2017539457A JP2017539457A JP2018510131A5 JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5 JP 2017539457 A JP2017539457 A JP 2017539457A JP 2017539457 A JP2017539457 A JP 2017539457A JP 2018510131 A5 JP2018510131 A5 JP 2018510131A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- active metabolite
- pharmaceutically
- och
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562110060P | 2015-01-30 | 2015-01-30 | |
| US62/110,060 | 2015-01-30 | ||
| US201562267350P | 2015-12-15 | 2015-12-15 | |
| US62/267,350 | 2015-12-15 | ||
| PCT/IB2016/050477 WO2016120850A1 (en) | 2015-01-30 | 2016-01-29 | Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018510131A JP2018510131A (ja) | 2018-04-12 |
| JP2018510131A5 true JP2018510131A5 (enExample) | 2019-06-20 |
Family
ID=55405379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017539457A Ceased JP2018510131A (ja) | 2015-01-30 | 2016-01-29 | Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10385036B2 (enExample) |
| EP (1) | EP3250561A1 (enExample) |
| JP (1) | JP2018510131A (enExample) |
| CA (1) | CA2975157C (enExample) |
| WO (1) | WO2016120850A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3250570A1 (en) | 2015-01-30 | 2017-12-06 | Pfizer Inc | Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| GB201709456D0 (en) * | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| KR102037494B1 (ko) | 2017-12-11 | 2019-10-28 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
| KR20190120112A (ko) | 2019-10-08 | 2019-10-23 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
| CN115322105A (zh) * | 2021-05-11 | 2022-11-11 | 江苏润安制药有限公司 | 一种合成艾拉莫德关键中间体的方法 |
| CN116135839A (zh) * | 2021-11-18 | 2023-05-19 | 江苏润安制药有限公司 | 一种阿齐沙坦关键中间体的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4742057A (en) | 1985-12-05 | 1988-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic thiazole compounds |
| GB9211276D0 (en) * | 1992-05-28 | 1992-07-15 | Glaxo Lab Sa | Pharmaceutical compositions |
| US5962473A (en) | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| EP1003738B1 (en) | 1997-08-09 | 2003-11-19 | SmithKline Beecham plc | Bicyclic compounds as ligands for 5-ht1 receptors |
| AU4425399A (en) | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
| BR0206595A (pt) * | 2001-01-30 | 2004-07-13 | Lilly Co Eli | Composto, composição farmacêutica, e uso de um composto |
| BR112014000315A2 (pt) | 2011-07-08 | 2016-08-23 | Syngenta Participations Ag | processos para a preparação de tietanamina |
| WO2014026329A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026330A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2014026328A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof |
| LT3027603T (lt) | 2013-08-02 | 2018-08-10 | Pfizer Inc. | Heterobicikloarilo rorc2 inhibitoriai ir jų panaudojimo būdai |
| MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
| EP3250570A1 (en) | 2015-01-30 | 2017-12-06 | Pfizer Inc | Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof |
-
2016
- 2016-01-29 US US15/547,228 patent/US10385036B2/en not_active Expired - Fee Related
- 2016-01-29 EP EP16705819.7A patent/EP3250561A1/en not_active Withdrawn
- 2016-01-29 WO PCT/IB2016/050477 patent/WO2016120850A1/en not_active Ceased
- 2016-01-29 JP JP2017539457A patent/JP2018510131A/ja not_active Ceased
- 2016-01-29 CA CA2975157A patent/CA2975157C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018510131A5 (enExample) | ||
| JP2013525433A5 (enExample) | ||
| HRP20210745T1 (hr) | Supstituirani spojevi tetrahidrokinolinona kao ror gama modulatori | |
| RU2013144579A (ru) | Ингибиторы киназы mst1 и способы их применения | |
| JP2014505033A5 (enExample) | ||
| HRP20201494T1 (hr) | Spojevi heteroaril-karboksamida kao inhibitori ripk2 | |
| JP2013523802A5 (enExample) | ||
| CA2797663A1 (en) | Compounds that modulate intracellular calcium | |
| JP2019518071A5 (enExample) | ||
| HRP20210252T1 (hr) | Heterociklički amidi kao inhibitori kinaze | |
| JP2016500661A5 (enExample) | ||
| JP2018515531A5 (enExample) | ||
| JP2020537657A5 (enExample) | ||
| JP2019514874A5 (enExample) | ||
| RU2015137756A (ru) | Макроциклические производные пиридазинона | |
| RU2019142795A (ru) | Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение | |
| JP2004529874A5 (enExample) | ||
| HRP20200016T1 (hr) | Amidno supstituirani tiazoli kao modulatori rorgamat | |
| JP2010526814A5 (enExample) | ||
| JP2019530699A5 (enExample) | ||
| JP2010535722A5 (enExample) | ||
| JP2015062072A5 (enExample) | ||
| RU2008140943A (ru) | Аналоги тиазолидиндиона | |
| HRP20160462T1 (hr) | Derivati 1-benzil-3-hidroksimetilindazola i njihova uporaba u liječenju bolesti baziranih na ekspresiji mcp-1, cx3cr1 | |
| RU2016129380A (ru) | Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием |